Woods J H
Department of Pharmacology, The University of Michigan Medical School, Ann Arbor 48109, USA.
J Clin Pharmacol. 1998 Sep;38(9):773-82.
A commentary on current national and international regulation of benzodiazepine-like drugs is presented. The policies and decision making associated with these regulations also are discussed, both in terms of historical mistakes and current problems. Finally, a proposal is made to improve the methods by which regulations are put into effect.
本文对当前苯二氮䓬类药物的国内和国际监管进行了评论。还讨论了与这些监管相关的政策和决策，包括历史错误和当前问题。最后，提出了改进监管实施方法的建议。
